| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency’s ‘Suspected Adverse Drug Reactions’ Database
|
Chiappini, Stefania
|
|
2016
|
|
7 |
p. 647-654
|
artikel
|
| 2 |
β-Adrenoceptor Drugs and Parkinson’s Disease: A Nationwide Nested Case–Control Study
|
de Germay, Sibylle
|
|
|
|
7 |
p. 763-772
|
artikel
|
| 3 |
A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia
|
Correll, C. U.
|
|
|
|
7 |
p. 659-679
|
artikel
|
| 4 |
Antidepressant-induced hyperprolactinaemia
|
Coker, Flora
|
|
2010
|
|
7 |
p. 563-574
|
artikel
|
| 5 |
Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database
|
Billioti de Gage, Sophie
|
|
2018
|
|
7 |
p. 673-684
|
artikel
|
| 6 |
Antipsychotic Drug Use and the Risk of Seizures: Follow-up Study with a Nested Case–Control Analysis
|
Bloechliger, Marlene
|
|
2015
|
|
7 |
p. 591-603
|
artikel
|
| 7 |
A Review of Adjunctive CNS Medications Used for the Treatment of Post-Surgical Pain
|
Rai, Ajit
|
|
2017
|
|
7 |
p. 605-615
|
artikel
|
| 8 |
A Review of Neuroprotection Pharmacology and Therapies in Patients with Acute Traumatic Brain Injury
|
McConeghy, Kevin W.
|
|
2012
|
|
7 |
p. 613-636
|
artikel
|
| 9 |
A Review of Neuroprotection Pharmacology and Therapies in Patients with Acute Traumatic Brain Injury
|
McConeghy, Kevin W.
|
|
|
|
7 |
p. 613-636
|
artikel
|
| 10 |
A Review of Treatment Options for Progressive Supranuclear Palsy
|
Stamelou, Maria
|
|
2016
|
|
7 |
p. 629-636
|
artikel
|
| 11 |
Ascorbic Acid to Manage Psychiatric Disorders
|
Moretti, Morgana
|
|
2017
|
|
7 |
p. 571-583
|
artikel
|
| 12 |
Asenapine: A Review in Schizophrenia
|
Plosker, Greg L.
|
|
2016
|
|
7 |
p. 655-666
|
artikel
|
| 13 |
Assessment and Management of Neuropsychiatric Symptoms in Parkinson’s Disease
|
Mueller, Christoph
|
|
2018
|
|
7 |
p. 621-635
|
artikel
|
| 14 |
Assessment of abuse potential of benzodiazepines from a prescription database using ‘doctor shopping’ as an indicator
|
Pradel, Vincent
|
|
2010
|
|
7 |
p. 611-620
|
artikel
|
| 15 |
Association Between Statin Use and Depressive Symptoms in a Large Community-Dwelling Older Population Living in Australia and the USA: A Cross-Sectional Study
|
Agustini, Bruno
|
|
2019
|
|
7 |
p. 685-694
|
artikel
|
| 16 |
Associations of Prescribed ADHD Medication in Pregnancy with Pregnancy-Related and Offspring Outcomes: A Systematic Review
|
Li, Lin
|
|
|
|
7 |
p. 731-747
|
artikel
|
| 17 |
Atypical Post-Injection Reactions with Delayed Onset Following Glatiramer Acetate 40 mg: Need for Titration?
|
Zecca, Chiara
|
|
2018
|
|
7 |
p. 653-660
|
artikel
|
| 18 |
Author’s Reply to Segura-Aguilar: Autophagosome maturation not autophagy induction is impaired in neurodegeneration
|
Fowler, Alan J.
|
|
2018
|
|
7 |
p. 687-688
|
artikel
|
| 19 |
Blocking LINGO-1 as a Therapy to Promote CNS Repair: From Concept to the Clinic
|
Mi, Sha
|
|
2013
|
|
7 |
p. 493-503
|
artikel
|
| 20 |
BRAF Mutations in CNS Tumors—Prognostic Markers and Therapeutic Targets
|
Muniz, Thiago P.
|
|
|
|
7 |
p. 587-598
|
artikel
|
| 21 |
Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine
|
Durham, Paul L.
|
|
2010
|
|
7 |
p. 539-548
|
artikel
|
| 22 |
Comment on: “Activating Autophagy as a Therapeutic Strategy for Parkinson’s Disease”
|
Segura-Aguilar, Juan
|
|
2018
|
|
7 |
p. 685-686
|
artikel
|
| 23 |
Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-Adjusted Indirect Comparison
|
Cohan, Stanley
|
|
|
|
7 |
p. 795-804
|
artikel
|
| 24 |
Correction to: Changes in Cataplexy Frequency in a Clinical Trial of Lower‑Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications
|
Dauvilliers, Yves
|
|
|
|
7 |
p. 785-786
|
artikel
|
| 25 |
Correction to: Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine
|
Blair, Hannah A.
|
|
|
|
7 |
p. 661
|
artikel
|
| 26 |
Cost Effectiveness of Pharmacotherapies for Attention-Deficit Hyperactivity Disorder
|
Wu, Eric Q.
|
|
2012
|
|
7 |
p. 581-600
|
artikel
|
| 27 |
Does Pharmacological Treatment of ADHD in Adults Enhance Parenting Performance? Results of a Double-Blind Randomized Trial
|
Waxmonsky, James G.
|
|
2014
|
|
7 |
p. 665-677
|
artikel
|
| 28 |
Dopaminergic Therapies for Non-motor Symptoms in Parkinson’s Disease
|
Schaeffer, Eva
|
|
2017
|
|
7 |
p. 551-570
|
artikel
|
| 29 |
Drug Treatment of Clinically Isolated Syndrome
|
Förster, Moritz
|
|
|
|
7 |
p. 659-676
|
artikel
|
| 30 |
Drug Treatment of Clinically Isolated Syndrome
|
Förster, Moritz
|
|
2019
|
|
7 |
p. 659-676
|
artikel
|
| 31 |
Early Morbidity and Mortality Following In Utero Exposure to Selective Serotonin Reuptake Inhibitors
|
Colvin, Lyn
|
|
2012
|
|
7 |
p. e1-e14
|
artikel
|
| 32 |
Early Switching Strategies in Antidepressant Non-Responders: Current Evidence and Future Research Directions
|
Kudlow, Paul A.
|
|
2014
|
|
7 |
p. 601-609
|
artikel
|
| 33 |
Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies
|
Doty, Richard L.
|
|
|
|
7 |
p. 781-794
|
artikel
|
| 34 |
Efficacy and Safety of Intravenous Valproate for Status Epilepticus: A Systematic Review
|
Trinka, Eugen
|
|
2014
|
|
7 |
p. 623-639
|
artikel
|
| 35 |
Endolysosome and Autolysosome Dysfunction in Alzheimer’s Disease: Where Intracellular and Extracellular Meet
|
Weering, Jan R. T. van
|
|
2019
|
|
7 |
p. 639-648
|
artikel
|
| 36 |
Erratum to: Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs
|
Jongen, Peter Joseph
|
|
2017
|
|
7 |
p. 603
|
artikel
|
| 37 |
Escitalopram in the treatment of major depressive disorder in adolescent patients
|
Yang, Lily P. H.
|
|
2010
|
|
7 |
p. 621-623
|
artikel
|
| 38 |
Eslicarbazepine Acetate: A Review of Its Use as Adjunctive Therapy in Refractory Partial-Onset Seizures
|
Keating, Gillian M.
|
|
2014
|
|
7 |
p. 583-600
|
artikel
|
| 39 |
Extended-Release Viloxazine Compared with Atomoxetine for Attention Deficit Hyperactivity Disorder
|
Price, Maxwell Z.
|
|
|
|
7 |
p. 655-660
|
artikel
|
| 40 |
[18F]Florbetaben: A Review in β-Amyloid PET Imaging in Cognitive Impairment
|
Syed, Yahiya Y.
|
|
2015
|
|
7 |
p. 605-613
|
artikel
|
| 41 |
Health-Related Quality of Life in Patients with Multiple Sclerosis: Impact of Disease-Modifying Drugs
|
Jongen, Peter Joseph
|
|
2017
|
|
7 |
p. 585-602
|
artikel
|
| 42 |
Improving Memory and Cognition in Individuals with Down Syndrome
|
Rafii, Michael S.
|
|
2016
|
|
7 |
p. 567-573
|
artikel
|
| 43 |
Increased Metabolic Potential, Efficacy, and Safety of Emerging Treatments in Schizophrenia
|
Meyer, Jonathan M.
|
|
|
|
7 |
p. 545-570
|
artikel
|
| 44 |
Interferons and Multiple Sclerosis: Lessons from 25 Years of Clinical and Real-World Experience with Intramuscular Interferon Beta-1a (Avonex)
|
Cohan, Stanley L.
|
|
|
|
7 |
p. 743-767
|
artikel
|
| 45 |
Intranasal Insulin as a Treatment for Alzheimer’s Disease: A Review of Basic Research and Clinical Evidence
|
Freiherr, Jessica
|
|
2013
|
|
7 |
p. 505-514
|
artikel
|
| 46 |
Lafora disease
|
Monaghan, Thomas S.
|
|
2010
|
|
7 |
p. 549-561
|
artikel
|
| 47 |
Long-Term Neuropsychological Outcomes from an Open-Label Phase I/IIa Trial of 2-Hydroxypropyl-β-Cyclodextrins (VTS-270) in Niemann-Pick Disease, Type C1
|
Farmer, Cristan A.
|
|
2019
|
|
7 |
p. 677-683
|
artikel
|
| 48 |
Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe
|
Coghill, David R.
|
|
2017
|
|
7 |
p. 625-638
|
artikel
|
| 49 |
Management of Cluster Headache
|
Tfelt-Hansen, Peer C.
|
|
2012
|
|
7 |
p. 571-580
|
artikel
|
| 50 |
Management of Sleep Disturbances Associated with Smith-Magenis Syndrome
|
Kaplan, Kevin A.
|
|
|
|
7 |
p. 723-730
|
artikel
|
| 51 |
MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study
|
Tourbah, Ayman
|
|
2018
|
|
7 |
p. 661-672
|
artikel
|
| 52 |
Medication errors in psychiatry
|
Procyshyn, Ric M.
|
|
2010
|
|
7 |
p. 595-609
|
artikel
|
| 53 |
Monoamine Oxidase Inhibitors (MAOIs) in Psychiatric Practice: How to Use them Safely and Effectively
|
Chamberlain, Samuel R.
|
|
|
|
7 |
p. 703-716
|
artikel
|
| 54 |
Natalizumab: Risk Stratification of Individual Patients with Multiple Sclerosis
|
Tur, Carmen
|
|
2014
|
|
7 |
p. 641-648
|
artikel
|
| 55 |
Neurocognitive, Neuroprotective, and Cardiometabolic Effects of Raloxifene: Potential for Improving Therapeutic Outcomes in Schizophrenia
|
Khan, Mohammad M.
|
|
2016
|
|
7 |
p. 589-601
|
artikel
|
| 56 |
Number, Duration, and Distribution of Wake Bouts in Patients with Insomnia Disorder: Effect of Daridorexant and Zolpidem
|
Di Marco, Tobias
|
|
|
|
7 |
p. 639-653
|
artikel
|
| 57 |
Nusinersen: A Review in 5q Spinal Muscular Atrophy
|
Hoy, Sheridan M.
|
|
2018
|
|
7 |
p. 689-696
|
artikel
|
| 58 |
Outcome Assessment in Trials of Pharmacological Treatments for Alcohol Use Disorders: Fair and Strict Testing
|
Rösner, Susanne
|
|
2019
|
|
7 |
p. 649-657
|
artikel
|
| 59 |
Overdose of Atypical Antipsychotics
|
Levine, Michael
|
|
2012
|
|
7 |
p. 601-611
|
artikel
|
| 60 |
Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management
|
Spiller, Henry A.
|
|
2013
|
|
7 |
p. 531-543
|
artikel
|
| 61 |
Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management
|
Spiller, Henry A.
|
|
|
|
7 |
p. 531-543
|
artikel
|
| 62 |
Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic Model
|
Hard, Marjie L.
|
|
2017
|
|
7 |
p. 617-624
|
artikel
|
| 63 |
Pharmacological Management of Bipolar Depression: Acute Treatment, Maintenance, and Prophylaxis
|
Vieta, Eduard
|
|
2013
|
|
7 |
p. 515-529
|
artikel
|
| 64 |
Pharmacological Management of Nightmares Associated with Posttraumatic Stress Disorder
|
Geldenhuys, Christoff
|
|
|
|
7 |
p. 721-737
|
artikel
|
| 65 |
Pharmacotherapeutic Options for Managing Pain in Multiple Sclerosis
|
Di Stefano, Giulia
|
|
|
|
7 |
p. 749-761
|
artikel
|
| 66 |
Pharmacotherapy for Adolescent Alcohol Use Disorder
|
Clark, Duncan B.
|
|
2012
|
|
7 |
p. 559-569
|
artikel
|
| 67 |
Pharmacotherapy of bipolar disorder in children and adolescents
|
Pfeifer, Jonathan C.
|
|
2010
|
|
7 |
p. 575-593
|
artikel
|
| 68 |
Piracetam for Aphasia in Post-stroke Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials
|
Zhang, Jie
|
|
2016
|
|
7 |
p. 575-587
|
artikel
|
| 69 |
Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment
|
Mazza, Mario Gennaro
|
|
|
|
7 |
p. 681-702
|
artikel
|
| 70 |
Post-Hoc Analyses of the Effects of Baseline Sleep Quality on SHP465 Mixed Amphetamine Salts Extended-Release Treatment Response in Adults with Attention-Deficit/Hyperactivity Disorder
|
Surman, Craig B. H.
|
|
2019
|
|
7 |
p. 695-706
|
artikel
|
| 71 |
Potential of Glial Cell Modulators in the Management of Substance Use Disorders
|
Jones, Jermaine D.
|
|
|
|
7 |
p. 697-722
|
artikel
|
| 72 |
Potential Role of Vitamin D for the Management of Depression and Anxiety
|
Casseb, Gleicilaine A. S.
|
|
2019
|
|
7 |
p. 619-637
|
artikel
|
| 73 |
Presynaptic Dopaminergic Function: Implications for Understanding Treatment Response in Psychosis
|
Bonoldi, I.
|
|
2014
|
|
7 |
p. 649-663
|
artikel
|
| 74 |
Prevention Studies in Alzheimer’s Disease: Progress Towards the Development of New Therapeutics
|
Coley, Nicola
|
|
2015
|
|
7 |
p. 519-528
|
artikel
|
| 75 |
Propofol: A Review of its Role in Pediatric Anesthesia and Sedation
|
Chidambaran, Vidya
|
|
2015
|
|
7 |
p. 543-563
|
artikel
|
| 76 |
Relevance of 5-HT2A Receptor Modulation of Pyramidal Cell Excitability for Dementia-Related Psychosis: Implications for Pharmacotherapy
|
Burstein, Ethan S.
|
|
|
|
7 |
p. 727-741
|
artikel
|
| 77 |
Restoring Axonal Function with 4-Aminopyridine: Clinical Efficacy in Multiple Sclerosis and Beyond
|
Leussink, Verena Isabell
|
|
2018
|
|
7 |
p. 637-651
|
artikel
|
| 78 |
Role of Estrogen Treatment in the Management of Schizophrenia
|
Kulkarni, Jayashri
|
|
2012
|
|
7 |
p. 549-557
|
artikel
|
| 79 |
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention
|
Leweke, F. Markus
|
|
2018
|
|
7 |
p. 605-619
|
artikel
|
| 80 |
Rotigotine Transdermal Patch: A Review in Parkinson’s Disease
|
Frampton, James E.
|
|
2019
|
|
7 |
p. 707-718
|
artikel
|
| 81 |
Sodium Channel Blockers in the Treatment of Epilepsy
|
Brodie, Martin J.
|
|
2017
|
|
7 |
p. 527-534
|
artikel
|
| 82 |
Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial
|
Dauvilliers, Yves
|
|
|
|
7 |
p. 773-784
|
artikel
|
| 83 |
Sphingosine 1-Phosphate Receptor Modulators in Multiple Sclerosis
|
Subei, Adnan M.
|
|
2015
|
|
7 |
p. 565-575
|
artikel
|
| 84 |
Stiff Man Syndrome
|
Meinck, Hans-Michael
|
|
|
|
7 |
p. 515-526
|
artikel
|
| 85 |
Synthesis and Comparison of the Meta-Analyses Evaluating the Efficacy of Memantine in Moderate to Severe Stages of Alzheimer’s Disease
|
Rive, Benoît
|
|
2013
|
|
7 |
p. 573-582
|
artikel
|
| 86 |
Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer’s Disease
|
Fülöp, Tamàs
|
|
|
|
7 |
p. 673-695
|
artikel
|
| 87 |
The Association Between the Occurrence of Common Treatment-Emergent Adverse Events and Efficacy Outcomes After Lasmiditan Treatment of a Single Migraine Attack: Secondary Analyses from Four Pooled Randomized Clinical Trials
|
Doty, Erin G.
|
|
|
|
7 |
p. 771-783
|
artikel
|
| 88 |
The Clinical Applications of Extended-Release Abuse-Deterrent Opioids
|
Vadivelu, Nalini
|
|
2016
|
|
7 |
p. 637-646
|
artikel
|
| 89 |
The Effect of Statin Treatment on Outcomes of Cardioembolic Stroke: A Systematic Review and Meta-Analysis of Real-World Studies
|
Xu, Tao
|
|
|
|
7 |
p. 717-726
|
artikel
|
| 90 |
The Molecular Mechanism of Glucagon-Like Peptide-1 Therapy in Alzheimer’s Disease, Based on a Mechanistic Target of Rapamycin Pathway
|
Li, Lin
|
|
2017
|
|
7 |
p. 535-549
|
artikel
|
| 91 |
The Prevalence, Measurement, and Treatment of the Cognitive Dimension/Domain in Major Depressive Disorder
|
McIntyre, Roger S.
|
|
2015
|
|
7 |
p. 577-589
|
artikel
|
| 92 |
The Safety of Atomoxetine for the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Comprehensive Review of Over a Decade of Research
|
Reed, Victoria A.
|
|
2016
|
|
7 |
p. 603-628
|
artikel
|
| 93 |
The Serotonin 1A (5-HT1A) Receptor as a Pharmacological Target in Depression
|
Smith, Alexander L. W.
|
|
|
|
7 |
p. 571-585
|
artikel
|
| 94 |
The Therapeutic Potential of α7 Nicotinic Acetylcholine Receptor (α7 nAChR) Agonists for the Treatment of the Cognitive Deficits Associated with Schizophrenia
|
Beinat, Corinne
|
|
2015
|
|
7 |
p. 529-542
|
artikel
|
| 95 |
The Two Sides of Siponimod: Evidence for Brain and Immune Mechanisms in Multiple Sclerosis
|
Cohan, Stanley L.
|
|
|
|
7 |
p. 703-719
|
artikel
|
| 96 |
Treatment with Methylphenidate for Attention Deficit Hyperactivity Disorder (ADHD) and the Risk of All-Cause Poisoning in Children and Adolescents: A Self-Controlled Case Series Study
|
Gao, Le
|
|
|
|
7 |
p. 769-779
|
artikel
|
| 97 |
Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System
|
Dávila, Guadalupe
|
|
|
|
7 |
p. 599-637
|
artikel
|
| 98 |
Using the Intranasal Route to Administer Drugs to Treat Neurological and Psychiatric Illnesses: Rationale, Successes, and Future Needs
|
Lofts, Andrew
|
|
|
|
7 |
p. 739-770
|
artikel
|
| 99 |
Vaccines Against Nicotine
|
Vocci, Frank J.
|
|
|
|
7 |
p. 505-514
|
artikel
|
| 100 |
Vitamin Supplementation in the Treatment of Schizophrenia
|
Brown, Hannah E.
|
|
2014
|
|
7 |
p. 611-622
|
artikel
|
| 101 |
Withdrawal Symptoms and Rebound Syndromes Associated with Switching and Discontinuing Atypical Antipsychotics: Theoretical Background and Practical Recommendations
|
Cerovecki, Anja
|
|
2013
|
|
7 |
p. 545-572
|
artikel
|
Tijdschrift beschrijving